Around 10 foreign firms filed for Hong Kong listings this year, from biotech to blockchain. Blockdaemon's filing could set precedent for crypto infrastructure IPOs in Asia.
Alpha Score of 50 reflects weak overall profile with moderate momentum, poor value, moderate quality, moderate sentiment.
Around 10 foreign firms have filed to list in Hong Kong this year, according to an HKEX executive, spanning sectors from biotech to blockchain infrastructure. The cohort includes Blockdaemon, a crypto-staking and node infrastructure provider. If all transactions go through, 2026 will mark the best year for foreign listings in Hong Kong since at least 2020.
For crypto firms, the read-through is narrower than the headline suggests. Blockdaemon is not a token issuer or exchange; it is infrastructure that sits between institutional capital and proof-of-stake networks. That distinction matters because Hong Kong's Securities and Futures Commission has been clearer on allowing infrastructure plays than on letting native crypto assets trade on its main exchange. The filing gives the market a live case study of how the regulator treats a crypto-adjacent equity.
The simple take is that foreign listings are picking up. The better market read, however, is that the composition tells you where global equity capital markets are willing to price risk. Biotech listings in Hong Kong are not new; they were a staple of the 2018 listing reform. Blockchain infrastructure is the fresh variable. If Blockdaemon prices successfully, it opens a pathway for other crypto-backbone firms to use Hong Kong as their primary listing venue, bypassing the SEC and the EU's Markets in Crypto-Assets regulation regimes.
Foreign issuers have historically treated Hong Kong as a bridge between China's capital pool and international governance standards. The current batch is not dominated by mainland China-linked companies – these are genuinely foreign-domiciled firms choosing Hong Kong over Nasdaq or the LSE. That shift is partly driven by ongoing trade tensions and partly by Hong Kong's efforts to offer a faster listing process for non-Chinese companies.
HKEX has been actively marketing to Southeast Asian and Middle Eastern issuers. The blockchain infrastructure cohort is a natural fit because many crypto staking and custody firms are Delaware-incorporated but serve global clients. A Hong Kong listing gives them access to Asian institutional investors while keeping a familiar common-law legal framework.
The next concrete marker is the HKEX hearing schedule for Blockdaemon's application. A successful listing would likely trigger a wave of copycat filings from similar infrastructure providers. Failure – either on regulatory grounds or pricing – would cool the pipeline and push crypto firms back to over-the-counter trades or backdoor listings via SPACs in the US.
Investors should watch the prospectus disclosures for Blockdaemon's exposure to staking yield variability and to the specific blockchains it supports. If the market prices a 30%+ haircut versus private valuations, that signals the bid-ask gap for crypto infrastructure is wider than for biotech. If it prices flat or above, the sector read-through is bullish for firms like Figment or Kiln that might file next.
This filing also intersects with regulatory moves elsewhere. Japan's June 1 stablecoin rules create a different compliance burden for crypto firms choosing their listing domicile. HKEX's willingness to accommodate infrastructure companies without demanding full token disclosure gives it a competitive edge over Tokyo and Singapore for these listings.
The 10 filings are not yet executed IPOs. The final test is whether the market absorbs them at the pricing range issuers want. For crypto infrastructure specifically, Blockdaemon's outcome determines whether Hong Kong becomes the default listing hub for blockchain operations or just another venue that proved too shallow for the sector. The next HKEX quarterly update will show whether more crypto firms have filed in the pipeline, which is the real signal for the thesis.
Prepared with AlphaScala research tooling and grounded in primary market data: live prices, fundamentals, SEC filings, hedge-fund holdings, and insider activity. Each story is checked against AlphaScala publishing rules before release. Educational coverage, not personalized advice.